This action relates to an Abbreviated New Drug Application (“ANDA”) filed by ZydusPharmaceuticals USA, Inc. with the U.S. Food and Drug Administration (“FDA”) seeking FDAapproval to market generic versions of the 15 mg and 30 mg dosages of Plaintiffs’SUPRENZA® drug product.This action relates to an Abbreviated New Drug Application (“ANDA”) filed by ZydusPharmaceuticals USA, Inc. with the U.S. Food and Drug Administration (“FDA”) seeking FDAapproval to market generic versions of the 15 mg and 30 mg dosages of Plaintiffs’SUPRENZA® drug product.
Complaint for Patent Infringement
Civil Action No. 1:13-cv-01143-UNA; no judge yet assigned.
Filed on June 26, 2013 in the U.S. District Court for the District of Delaware;
Patent in suit:
Complaint for Patent Infringement
Civil Action No. 1:13-cv-01143-UNA; no judge yet assigned.
Filed on June 26, 2013 in the U.S. District Court for the District of Delaware;
Patent in suit:
- 6,149,938: “Process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble.” by Bonadeo et. al. Prosecuted by Anderson; Kirsten A.. Includes 8 claims (1 indep.). Was application 09/122,037. Granted 11/21/2000.